A Multicentre Observational Cross-Sectional Study of The Gastric Precancerous Epithelial Pathway Using High-Definition Endoscopy And Histopathology In India
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
To estimate the prevalence of histologically confirmed early gastric cancer (EGC) in an Indian multicentre cohort undergoing standardised high-quality upper gastrointestinal endoscopy. EGC is defined as gastric adenocarcinoma confined to the mucosa or submucosa (T1), irrespective of lymph node status, based on histopathology.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 40 lat lub więcej
- •Pacjenci poddawani badaniu górnego przewodu pokarmowego (żołądka i przełyku)
- •Zgoda na uczestnictwo w badaniu
✗ Disqualifies
- •Znany rak żołądka
- •Poprzednia operacja żołądka (z wyjątkiem leczenia infekcji H. pylori)
- •Przeciwwskazania do badania endoskopowego lub pobrania próbki tkanki
- •Dziedziczne zespoły raka żołądka w rodzinie
Simplified criteria — AI translation
Trial details
- Minimum age
- 40 Years
- Last updated (source)
- August 31, 2026
- Sex
- No restrictions
Locations (1)
AIG Hospitals
Hyderabad, India
Trial contact
Dr.Hardik Rughwani Dr.Hardik Rughwani, MBBS, MD, DM
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.